Elos Medtech Balance Sheet Health

Financial Health criteria checks 6/6

Elos Medtech has a total shareholder equity of SEK788.2M and total debt of SEK407.1M, which brings its debt-to-equity ratio to 51.6%. Its total assets and total liabilities are SEK1.6B and SEK772.0M respectively. Elos Medtech's EBIT is SEK136.9M making its interest coverage ratio 3.2. It has cash and short-term investments of SEK117.3M.

Key information

51.6%

Debt to equity ratio

kr407.10m

Debt

Interest coverage ratio3.2x
Cashkr117.30m
Equitykr788.20m
Total liabilitieskr772.00m
Total assetskr1.56b

Recent financial health updates

We Think Elos Medtech (STO:ELOS B) Is Taking Some Risk With Its Debt

Mar 24
We Think Elos Medtech (STO:ELOS B) Is Taking Some Risk With Its Debt

Elos Medtech (STO:ELOS B) Has A Somewhat Strained Balance Sheet

Dec 13
Elos Medtech (STO:ELOS B) Has A Somewhat Strained Balance Sheet

Recent updates

Calculating The Fair Value Of Elos Medtech AB (publ) (STO:ELOS B)

Oct 11
Calculating The Fair Value Of Elos Medtech AB (publ) (STO:ELOS B)

Is Now The Time To Look At Buying Elos Medtech AB (publ) (STO:ELOS B)?

May 23
Is Now The Time To Look At Buying Elos Medtech AB (publ) (STO:ELOS B)?

Here's Why I Think Elos Medtech (STO:ELOS B) Is An Interesting Stock

May 10
Here's Why I Think Elos Medtech (STO:ELOS B) Is An Interesting Stock

Returns On Capital Are Showing Encouraging Signs At Elos Medtech (STO:ELOS B)

Apr 17
Returns On Capital Are Showing Encouraging Signs At Elos Medtech (STO:ELOS B)

We Think Elos Medtech (STO:ELOS B) Is Taking Some Risk With Its Debt

Mar 24
We Think Elos Medtech (STO:ELOS B) Is Taking Some Risk With Its Debt

Should Elos Medtech AB (publ) (STO:ELOS B) Be Part Of Your Dividend Portfolio?

Mar 11
Should Elos Medtech AB (publ) (STO:ELOS B) Be Part Of Your Dividend Portfolio?

The President & CEO of Elos Medtech AB (publ) (STO:ELOS B), Jan Wahlström, Just Bought 28% More Shares

Feb 28
The President & CEO of Elos Medtech AB (publ) (STO:ELOS B), Jan Wahlström, Just Bought 28% More Shares

Do Fundamentals Have Any Role To Play In Driving Elos Medtech AB (publ)'s (STO:ELOS B) Stock Up Recently?

Feb 24
Do Fundamentals Have Any Role To Play In Driving Elos Medtech AB (publ)'s (STO:ELOS B) Stock Up Recently?

Elos Medtech (STO:ELOS B) Has Gifted Shareholders With A Fantastic 102% Total Return On Their Investment

Feb 11
Elos Medtech (STO:ELOS B) Has Gifted Shareholders With A Fantastic 102% Total Return On Their Investment

When Should You Buy Elos Medtech AB (publ) (STO:ELOS B)?

Jan 31
When Should You Buy Elos Medtech AB (publ) (STO:ELOS B)?

How Much Are Elos Medtech AB (publ) (STO:ELOS B) Insiders Taking Off The Table?

Jan 18
How Much Are Elos Medtech AB (publ) (STO:ELOS B) Insiders Taking Off The Table?

Returns On Capital At Elos Medtech (STO:ELOS B) Paint An Interesting Picture

Jan 06
Returns On Capital At Elos Medtech (STO:ELOS B) Paint An Interesting Picture

Could The Elos Medtech AB (publ) (STO:ELOS B) Ownership Structure Tell Us Something Useful?

Dec 26
Could The Elos Medtech AB (publ) (STO:ELOS B) Ownership Structure Tell Us Something Useful?

Elos Medtech (STO:ELOS B) Has A Somewhat Strained Balance Sheet

Dec 13
Elos Medtech (STO:ELOS B) Has A Somewhat Strained Balance Sheet

Here's Why We Don't Think Elos Medtech's (STO:ELOS B) Statutory Earnings Reflect Its Underlying Earnings Potential

Nov 30
Here's Why We Don't Think Elos Medtech's (STO:ELOS B) Statutory Earnings Reflect Its Underlying Earnings Potential

Elos Medtech AB (publ)'s (STO:ELOS B) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Nov 17
Elos Medtech AB (publ)'s (STO:ELOS B) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Financial Position Analysis

Short Term Liabilities: ELOS B's short term assets (SEK577.9M) exceed its short term liabilities (SEK289.8M).

Long Term Liabilities: ELOS B's short term assets (SEK577.9M) exceed its long term liabilities (SEK482.2M).


Debt to Equity History and Analysis

Debt Level: ELOS B's net debt to equity ratio (36.8%) is considered satisfactory.

Reducing Debt: ELOS B's debt to equity ratio has reduced from 57.1% to 51.6% over the past 5 years.

Debt Coverage: ELOS B's debt is well covered by operating cash flow (23.4%).

Interest Coverage: ELOS B's interest payments on its debt are well covered by EBIT (3.2x coverage).


Balance Sheet


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.